CDHR2 Antikörper (AA 151-250)
-
- Target Alle CDHR2 Antikörper anzeigen
- CDHR2 (Cadherin-Related Family Member 2 (CDHR2))
-
Bindungsspezifität
- AA 151-250
- Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser CDHR2 Antikörper ist unkonjugiert
- Applikation
- Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), ELISA, Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunocytochemistry (ICC)
- Homologie
- Human,Mouse,Rat,Pig
- Aufreinigung
- Purified by Protein A.
- Immunogen
- KLH conjugated synthetic peptide derived from human PCLKC
- Isotyp
- IgG
- Top Product
- Discover our top product CDHR2 Primärantikörper
-
-
- Applikationshinweise
-
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200
ICC 1:100-500 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 μg/μL
- Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
- Haltbarkeit
- 12 months
-
- Target
- CDHR2 (Cadherin-Related Family Member 2 (CDHR2))
- Andere Bezeichnung
- PCLKC (CDHR2 Produkte)
- Synonyme
- PCDH24 antikoerper, PCLKC antikoerper, cadherin related family member 2 antikoerper, CDHR2 antikoerper
- Hintergrund
-
Synonyms: FLJ20124, FLJ20383, MGC163154, PC LKC,PC-LKC, Protocadherin LKC.
Background: PCLKC (Protocadherin LKC) belongs to the protocadherin gene family, a subgroup of the cadherin superfamily. It is predominantly expressed in liver, kidney and colon tissues, and has a role in contact inhibition at the lateral surface of epithelial cells. It is a candidate tumor suppressor.
-